Molecular Templates, Inc.
MTEMDelisted May 22, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001183765
Molecular Templates, Inc. was delisted on May 22, 2025; its insiders filed their last Form 4 on Nov 18, 2024; no institution reported holding it in 13F filings for Q1 2025; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Molecular Templates, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −3 vs. Q2 2024
- Shares held
- 2.71M
- −71.9K (−2.6%) vs. Q2 2024
- Total value
- $3.71M
- +$506.5K (+15.8%) vs. Q2 2024
- New holders
- 2
- 3 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 3 | $4 |
| Q3 2024 | 24 | $3.71M |
| Q2 2024 | 28 | $3.25M |
| Q1 2024 | 29 | $6.00M |
| Q4 2023 | 29 | $10.2M |
| Q3 2023 | 30 | $17.4M |
| Q2 2023 | 41 | $11.5M |
| Q1 2023 | 41 | $9.28M |
| Q4 2022 | 50 | $9.21M |
| Q3 2022 | 58 | $23.4M |
| Q2 2022 | 65 | $29.8M |
| Q1 2022 | 77 | $124.6M |
| Q4 2021 | 79 | $140.3M |
| Q3 2021 | 86 | $249.4M |
| Q2 2021 | 89 | $275.4M |
| Q1 2021 | 102 | $445.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Molecular Templates, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Group AG | 1,279,820 | $1.80M | 0.03% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 623,838 | $876.5K | 0.20% | 00.0% | Unchanged |
| BVF Inc | 522,238 | $733.7K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 50,899 | $71.5K | 0.00% | −9,707−16.0% | Reduced |
| Geode Capital Management, LLC | 47,231 | $66.4K | 0.00% | +5,240+12.5% | Added |
| BlackRock, Inc. | 38,130 | $53.6K | 0.00% | +38,130 | New |
| Invst, LLC | 23,400 | $32.9K | 0.00% | +5,399+30.0% | Added |
| Renaissance Technologies LLC | 14,053 | $19.7K | 0.00% | +200+1.4% | Added |
| State Street Corp | 13,676 | $19.2K | 0.00% | 00.0% | Unchanged |
| Carlyle Group Inc. | 13,333 | $18.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,201 | $7.31K | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 3,333 | $4.68K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,231 | $4.54K | 0.00% | −2,793−46.4% | Reduced |
| Acadian Asset Management LLC | 1,300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 475 | $668 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 354 | $496 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 271 | $380 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 37 | $52 | 0.00% | 00.0% | Unchanged |
| Arcadia Investment Management Corp | 6 | $9 | 0.00% | 00.0% | Unchanged |
| Tortoise Investment Management, LLC | 6 | $8 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 2 | $3 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $1 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 66 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 73,125 | – | – | +73,125 | New |
| Caxton Corp | 0 | $0 | 0.00% | −136,866−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,477−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −15,173−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,953−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |